India refuses patent protection for two key HIV drugs.
In September 2009, the Indian Patent Office (IPO) rejected applications for patents from two U.S. pharmaceutical companies for tenofovir and darunavir.
D019380:Anti-HIV Agents; D007194:India; D010330:Patents as Topic
D019380:Anti-HIV Agents